To determine whether the velocity of IFT trains is affected by acute ciliobrevin treatment, we 1 2 5 next generated direction-filtered kymographs and extracted position-dependent velocities of 1 2 6 XBX-1::EGFP using KymographClear and KymographDirect (Fig 1D, E) [27]. In the 1 2 7 retrograde direction (tip to base, Fig 1D) IFT dynein is the active driver of transport, but in the 1 2 8 anterograde direction (base to tip, Fig 1E) IFT dynein is carried as cargo by the kinesin-2 1 2 9 family motors OSM-3 and kinesin-II. We found that retrograde IFT-train velocity is reduced by 1 3 0 ~12%, suggesting rapid inhibition of (at least some) IFT-dynein motors participating in 1 3 1 transport. Interestingly, kinesin-2-driven anterograde transport was also reduced (~21%). 1 3 2
While the original report by Firestone et al suggested that ciliobrevin A and D do not affect 1 3 3 kinesin-1-dependent microtubule gliding in in vitro assays with only kinesin-1, our data is 1 3 4 consistent with studies in primary neurons showing that ciliobrevin D affects both 1 3 5
anterograde and retrograde transport [16, 28] . Similarly, in Chlamydomonas, anterograde 1 3 6 transport impairment occurs already 2 minutes after treatment [19] . It is possible that 1 3 7 ciliobrevin is not specific to the cytoplasmic dynein ATP binding site, but interpretation of 1 3 8 these findings is difficult owing to the strong interdependence between anterograde and 1 3 9 retrograde transport [29] . Functional IFT requires continuous turnover and impairment of 1 4 0 retrograde transport could thus indirectly lead to impairment of anterograde transport [30] . 1 4 1
Another possibility is that anterograde IFT trains require functional, uninhibited dynein motors 1 4 2
Next, we used the long-exposure fluorescence images to visualize the effect of ciliobrevin A 1 4 4 on XBX-1 distribution. In all control-treated cilia there were no visible accumulations of 1 4 5 motors along the cilium (Fig 1B, F) . In 15.4% of the acutely ciliobrevin-treated cilia, however, 1 4 6 we observed XBX-1 accumulations at non-specific locations along the cilium (Fig 1F, G) . We 1 4 7 attribute these "roadblock" accumulations to inhibition of a small subset of IFT-dynein motors, 1 4 8 resulting in stalled IFT trains. These non-moving IFT trains can be bypassed by active 1 4 9 motors (Movie S1), indicating that they do not completely block IFT. Taken together, our 1 5 0 findings affirm the efficacy of ciliobrevin A in the phasmid cilia of living C. elegans. 1 5 1 Importantly, we show that acute IFT-dynein inhibition using a minimal ciliobrevin 1 5 2 concentration does not completely halt IFT. While the number of functional dynein motors is 1 5 3 likely diminished, IFT is maintained, albeit at a lower velocity, resulting in a reduced ciliary 1 5 4 length. 1 5 5 1 5 6 1 5 7 To explore the effect of more prolonged inhibition of IFT dynein, we subjected nematodes to 1 6 0 1 hour treatment with low-and high-concentration ciliobrevin (0.7 and 1.4 mM in 2% DMSO, 1 6 1 respectively), or 2% DMSO solution as control. Due to the limited solubility of ciliobrevin and 1 6 2 DMSO toxicity (above 2% V/V), 1.4 mM was the highest ciliobrevin concentration attainable 1 6 3 in our experiments. In control-treated nematodes, the average distance occupied by motors 1 6 4 was 8.25 ± 0.18 µm, similar to control experiments with 1% DMSO (Fig 2A) . After 1-hour 1 6 5 treatment with 0.7 mM and 1.4 mM ciliobrevin, cilia appeared shorter and the average length 1 6 6 occupied by XBX-1∷EGFP reduced to 6.91 ± 0.17 µm and 6.11 ± 0.30 µm respectively. To 1 6 7 probe whether the observed shortening is due to motor retraction or axonemal shortening, 1 6 8 we also exposed animals with labeled ciliary tubulin TBB-4::EGFP to 1.4 mM ciliobrevin 1 6 9 solution. The average cilium length in these animals was 5.59 ± 0.22 µm (Fig 2A) , confirming 1 7 0 that ciliobrevin induces retraction of the axoneme. To obtain further insight into ciliary 1 7 1 shortening, we plotted the distribution of post-treatment length occupied by XBX-1 for each 1 7 2 treatment (Fig 2A) . While in all low-concentration-treated worms XBX-1 extended from base 1 7 3 to beyond the proximal segment, in some high-concentration treated worms we observed 1 7 4
Prolonged ciliobrevin A treatment leads to concentration-
XBX-1 only occupying the first 2 -4 µm of the cilium, most likely indicating retraction of (part 1 7 5 of) the proximal segment. Such severe truncations were not observed with acute or 1 7 6 prolonged low-concentration treatment, revealing concentration-dependent ciliary shortening 1 7 7 in response to prolonged ciliobrevin treatment ( Fig 1C, Fig 2A) . We next investigated the effect of prolonged ciliobrevin treatment on IFT-motor velocity using 2 0 9 a dual-label C. elegans strain with fluorescently-tagged IFT dynein and one of the 2 1 0 anterograde kinesin-2 motors, OSM-3 [22] . We recorded fluorescence image sequences of 2 1 1 IFT dynein (XBX-1::EGFP) and OSM-3 (OSM-3::mCherry) and generated kymographs. Position-dependent velocities were then extracted using KymographClear and 2 1 3 KymographDirect (Fig 2B, C) [27] . Prolonged treatment with ciliobrevin resulted in a ~24% (at 2 1 4 0.7 mM) and ~36% (at 1.4 mM) lower retrograde IFT-dynein velocity ( Fig 2B) . The 2 1 5 anterograde (OSM-3) velocity was also reduced, by ~31% (at 0.7 mM) and ~34% (at 1.4 mM; 2 1 6 Fig 2C) . These results show that higher concentrations of ciliobrevin and longer exposure to 2 1 7 the drug result in a larger reduction of the velocity in both directions. To further explore the 2 1 8 relationship between cilium length and IFT velocity, we plotted the maximum anterograde 2 1 9 ( Fig 2D) and retrograde (Fig 2E) velocity for each cilium. We observe a clear trend 2 2 0 (Pearson's r = 0.70 and 0.63 for XBX-1 and OSM-3 respectively) between maximally attained 2 2 1 IFT velocities and length of cilium occupied by motors, suggesting that the extent of ciliary 2 2 2 shortening could be velocity-dependent. To investigate the effect of prolonged ciliobrevin A exposure on IFT-dynein distribution, we 2 2 6 characterized the extent of IFT-dynein accumulations after high-and low-concentration 2 2 7 treatment (Fig 3) . As expected, in control-treated nematodes there were no aberrant motor 2 2 8 accumulations (2% DMSO; Fig 3A) . In nematodes that underwent prolonged, low-2 2 9 concentration treatment, 50% of phasmid cilia had no motor accumulations and 29% had 2 3 0 "roadblock" accumulations at apparently random positions along the cilium. In a smaller 2 3 1 fraction of the cilia (9%) we observed IFT-dynein accumulations only at the ciliary tip ( and Chlamydomonas [19] . In some cilia (12%), motor accumulation in the distal segment 2 3 5 was more substantial, covering at least 1 µm of the distal segment including tip ( Fig 3C) . In 2 3 6 nematodes that underwent prolonged, high-concentration ciliobrevin treatment we observed 2 3 7 more severe disruptions of the IFT-dynein distribution. 13% of the cilia showed motor 2 3 8 accumulation only at the tip, while in 33% of cilia dynein motors had stalled in the entire distal 2 3 9 segment, substantially affecting the integrity of the axoneme (Fig 3C) . We hypothesize that in 2 4 0 these nematodes there are too few active IFT-dynein motors left to maintain bidirectional IFT, 2 4 1 resulting in (partial) collapse of the axoneme. In some cases, we observed a remarkable 2 4 2 heterogeneity in the response to ciliobrevin between the two cilia in a phasmid pair within 2 4 3 one organism, despite identical exposure. In the example shown in Fig 3B, one phasmid 2 4 4 cilium is substantially shortened while the other has maintained its full length. These 2 4 5 observations suggest that there is a balance point in the number of functional IFT 2 4 6 components required for distal segment maintenance and structural integrity ( Fig 3F) . In this 2 4 7 view, only a small fluctuation of component numbers below this balance point, in a given 2 4 8 cilium at a given time, will result in collapse of IFT and ciliary structure. In addition, after 2 4 9
Materials and Methods
3 1 2 C. elegans strains and dosing 3 1 3 C. elegans were maintained according to standard procedures. Nematodes were grown at 3 1 4 20°C on Nematode Growth Medium (NGM) plates seeded with Escherichia coli OP50 3 1 5 bacteria. The strains used in this study, EJP212 (XBX-1::EGFP, OSM-3::mCherry) [22] and 3 1 6 EJP401 (TBB4::EGFP), were generated using Mos1-mediated single-copy insertion 3 1 7 (MosSCI) [36] . Ciliobrevin A powder (H4541, Sigma Aldrich) was dissolved in fresh DMSO at 3 1 8 maximum solubility to make a 140 mM stock solution stored at -20°C for a maximum of 1 3 1 9 month (after 1 month we observed loss of efficacy). The ciliobrevin dosing solution was made 3 2 0 by diluting this stock solution in M9 to 1.4 mM (2% (V/V) DMSO content) or 0.7 mM (1% 3 2 1 DMSO content) and used the same day. Control (vehicle) dosing solutions were made by 3 2 2 dissolving DMSO in M9 (1% and 2% DMSO). Young adult hermaphrodites were dosed by 3 2 3 transferring to standard 0.2 ml PCR tubes (Thermo Scientific) with 0.7 mM or 1.4 mM 3 2 4 ciliobrevin solution for 5 min or 60 min. Nematodes were allowed to recover on unseeded 3 2 5 NGM plates for 2-3 minutes post-dosing. 3 2 6
Fluorescence imaging and analysis 3 2 7 C. elegans were anesthetized with 5mM levamisole in M9 and immobilized on a 2% agarose 3 2 8
